Delivery Order SPE2DB20D3101-SPE2DB23FRDE8

Award Date 2/22/23
Potential Completion Date 2/23/23
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,004.96, is for the delivery of Difluprednate 0.05% eye drops in 5 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of...
This contract award, valued at $3,179.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% eye drops in 5ml quantities. This is a firm-fixed price delivery order contract with a completion date of February 14, 2023. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the Amerisourcebergen Corporation. The $5,003.35 contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.56, is a Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a ceiling value of $14,663.65. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, which has a maximum value of $999,999,999.00 and runs through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Difluprednate 0.05% eye drops in 5mL volumes. The $1,171.84 contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award, valued at $11,003.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
This federal contract award, valued at $11,601.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Difluprednate 0.05% eye drops in 5 ml bottles. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,555.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Difluprednate 0.05% eye drops in 5ML vials. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB23FL34T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,701.72 delivery order is for the supply of Difluprednate 0.05% eye drop, a prescription medication, to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRDE8
    Delivery Order

This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company's federal contract awards demonstrate its ability to supply a broad range of pharmaceutical products and medical supplies to support the healthcare needs of service members, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:27 PM